Developmental impact on trans-acting dos
β
Jennifer L. Cooper; James A. Birchler
π
Article
π
2001
π
John Wiley and Sons
π
English
β 219 KB
## Abstract Summary: The reduction in vigor or viability caused by aneuploidy may be the result of __trans__βacting dosage effects that reduce gene expression. To investigate the molecular and developmental parameters of aneuploid syndromes, the expression of __sucrose synthase1 (sus1)__ and __shru